These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4182)

  • 41. [Anti-complement activity of some beta-adrenergic blocking agents. Research in vitro and in vivo].
    Di Perri T; Auteri A
    Boll Soc Ital Biol Sper; 1974 Sep; 50(17):1409-15. PubMed ID: 4156472
    [No Abstract]   [Full Text] [Related]  

  • 42. [Comparative pharmacological studies on beta-adrenolytic agents. An analysis of quantitative activity (author's transl)].
    Zechel HJ
    Arzneimittelforschung; 1977; 27(5):991-9. PubMed ID: 18159
    [No Abstract]   [Full Text] [Related]  

  • 43. Pharmacological studies on the intrinsic sympathomimetic activity of the beta-adrenoceptor antagonist mepindolol.
    Beckmann R; Müller B; Schröder G; Stock G
    Arzneimittelforschung; 1986 May; 36(5):811-3. PubMed ID: 2873820
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Celiprolol does not protect against ventricular tachycardia or sudden death in the conscious canine: a comparison with pindolol in assessing the role of intrinsic sympathomimetic activity.
    Uprichard AC; Chi LG; Kitzen JM; Lynch JJ; Frye JW; Lucchesi BR
    J Pharmacol Exp Ther; 1989 Nov; 251(2):571-7. PubMed ID: 2572693
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cardiovascular effects of beta-adrenoreceptor blocking agents after intracerebroventricular administration in conscious normotensive cats.
    Day MD; Roach AG
    Clin Exp Pharmacol Physiol; 1974; 1(4):333-9. PubMed ID: 4156505
    [No Abstract]   [Full Text] [Related]  

  • 46. [Inotropic effects of several adrenergic beta blockers in a dog subjected to electrosystolic cardiac impulse].
    Cheymol G; Mouillé P; Schmitt H; Laubie M
    Arch Int Pharmacodyn Ther; 1973 Sep; 205(1):45-51. PubMed ID: 4148408
    [No Abstract]   [Full Text] [Related]  

  • 47. The effect of intrinsic sympathomimetic activity of beta-adrenoceptor blockers on circadian heart rate.
    Fitscha P; Tiso B; Meisner W; Spitzer D
    Br J Clin Pharmacol; 1982; 13(Suppl 2):211S-215S. PubMed ID: 6125172
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Renin-suppressive potency of various beta-adrenergic blocking agents at supine rest and during upright exercise.
    Bühler FR; Marbet G; Patel U; Burkart F
    Clin Sci Mol Med Suppl; 1975 Jun; 2():61s-64s. PubMed ID: 28879
    [No Abstract]   [Full Text] [Related]  

  • 49. Vasodilating properties of beta-adrenoceptor blockers with intrinsic sympathomimetic activity.
    Thulesius O; Gjöres JE; Berlin E
    Br J Clin Pharmacol; 1982; 13(Suppl 2):229S-230S. PubMed ID: 6125174
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 6. A comparison of pindolol and propranolol in treatment of patients with angina pectoris. The role of intrinsic sympathomimetic activity.
    Frishman W; Kostis J; Strom J; Hossler M; Elkayam U; Goldner S; Silverman R; Davis R; Weinstein J; Sonnenblick E
    Am Heart J; 1979 Oct; 98(4):526-35. PubMed ID: 39447
    [No Abstract]   [Full Text] [Related]  

  • 51. Intrinsic sympathomimetic activity of cardioselective beta-adrenoceptor blockers and effects on renal function.
    Mackay IG; Macnicol AM; Smith HJ; Cumming AD; Watson ML
    Br J Clin Pharmacol; 1985 Sep; 20(3):197-203. PubMed ID: 2864052
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Central propranolol and pindolol, but not atenolol nor metoprolol, inhibit sexual behavior in male rats.
    Smith ER; Kacker SR; Raskin A; Yun PT; Davidson JM; Hoffman BB; Clark JT
    Physiol Behav; 1996 Feb; 59(2):241-6. PubMed ID: 8838601
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immediate central hemodynamic effects of five different beta-adrenoceptor-blocking agents, acebutolol, atenolol, pindolol, practolol, and propranolol, in patients with ischemic heart disease.
    Svendsen TL; Trap-Jensen J; Carlsen JE; McNair A
    Am Heart J; 1985 May; 109(5 Pt 2):1145-50. PubMed ID: 2859778
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Large arteries in hypertension: heterogeneous haemodynamic response to beta-adrenoceptor antagonists with and without intrinsic sympathomimetic activity.
    Simon AC; Levenson J; Pithois-Merli I
    Br J Clin Pharmacol; 1987; 24 Suppl 1(Suppl 1):45S-49S. PubMed ID: 2894224
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the effects of nine beta-adrenergic blocking agents on intraocular pressure in rabbits.
    Bonomi L; Perfetti S; Noya E; Bellucci R; Massa F
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1979 Mar; 210(1):1-8. PubMed ID: 35031
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative effects of propranolol, pindolol, and practolol after excision of the sinoatrial node in dogs.
    Fabry-Delaigue R; Duchêne-Marullaz P; Lemaire P; Kantelip JP
    J Cardiovasc Pharmacol; 1981; 3(5):1082-92. PubMed ID: 6168853
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of beta-adrenoceptor antagonist administration on beta 2-adrenoceptor density in human lymphocytes. The role of the "intrinsic sympathomimetic activity".
    Brodde OE; Daul A; Stuka N; O'Hara N; Borchard U
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Feb; 328(4):417-22. PubMed ID: 2859531
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The influence of beta-adrenoceptor blocking drugs with and without intrinsic sympathomimetic activity on the hormonal responses to hypo- and hyperglycaemia.
    Schlüter KJ; Aellig WH; Petersen KG; Rieband HC; Wehrli A; Kerp L
    Br J Clin Pharmacol; 1982; 13(Suppl 2):407S-417S. PubMed ID: 6125193
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The influence of beta-adrenoceptor blockers with and without intrinsic sympathomimetic activity on heart rate, arrhythmias and ST-T segments, using ambulatory electrocardiography.
    Northcote RJ; Ballantyne D
    Br J Clin Pharmacol; 1988 Feb; 25(2):179-85. PubMed ID: 3358881
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Estimation of the nonspecific cardiovascular toxicity of beta-adrenoceptor blocking drugs with different hydrophobic properties in the cat.
    Hellenbrecht D; Enenkel J
    Arzneimittelforschung; 1984; 34(9):980-3. PubMed ID: 6150722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.